The Food and Drug Administration (FDA), Center for Biologics Evaluation and Research (CBER), is announcing a public workshop entitled “Synergizing Efforts in Standards Development for Cellular Therapies and Regenerative Medicine Products.” The purpose of the public workshop is to bring together a broad range of stakeholders to discuss current and future standards development activities involving cellular therapies and regenerative medicine products.
Workshop Info:
October 7, 2013
8:30 a.m - 4:30 p.m.
FDA White Oak Campus
The Great Room, Bldg. 31
10903 New Hampshire Ave
Silver Spring, MD 20993
The public workshop will also be available to be viewed online via webcast. Read more
